Patents by Inventor Mathew Alexander

Mathew Alexander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Haemopoietic growth factor antagonists and uses therefor
    Patent number: 6322791
    Abstract: The present invention relates generally to variant recombinant forms of haemopoietic growth factors useful as antagonists to the corresponding native haemopoietic growth factor and their use in ameliorating aberrant effects caused by the native molecules and in the treatment of tumours and cancers and inflammation.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: November 27, 2001
    Assignee: BreasaGen Limited
    Inventors: Mathew Alexander Vadas, Angel Francisco Lopez, Mary Francis Shannon, Keat-Chye Cheah, Carol Ruth Senn, Stan Bastiras, Allan Robins
  • Control of annual grass weeds
    Patent number: 6008159
    Abstract: Method for controlling the proliferation of annual grass weeds in an area by applying to the area a composition of one or more species of Pyrenophora fungi or anamorphs thereof, or a toxin or toxin-containing preparation derived from one or more species of Pyrenophora fungi or anamorphs thereof in association with an agriculturally acceptable carrier.
    Type: Grant
    Filed: June 17, 1997
    Date of Patent: December 28, 1999
    Assignee: Minister of Agriculture for the State of New South Wales
    Inventors: Richard William Medd, Mathew Alexander Campbell
  • Modified forms of granulocyte macrophage-colony stimulating factor as antagonists
    Patent number: 5939063
    Abstract: The present invention relates to modified and variant forms of haemopoietic growth factors (HGF) capable of acting as antagonists to the corresponding native haemopoietic growth factors and their use in ameliorating aberrant effects caused by the native molecules. A modified haemopoietic growth factor (HGF) is characterized by being in unglycosylated form and comprising a sequence of amino acids within a first .alpha.-helix wherein one or more exposed amino acids in said first .alpha.-helix having acidic or acidic-like properties are substituted with a basic amino acid residue. The preferred HGF are granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, G-CSF and erythropoietin (EPO).
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: August 17, 1999
    Assignee: Medvet Science Pty. Ltd.
    Inventors: Mathew Alexander Vadas, Angel Francisco Lopez, Mary Frances Shannon